Page last updated: 2024-09-04

resiquimod and Anthrax

resiquimod has been researched along with Anthrax in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ainslie, KM; Bachelder, EM; Bell, MG; Borteh, H; Elberson, MA; Fonseca, ME; Gallovic, M; Keane-Myers, A; Peine, KJ; Pesce, J; Prouty, AM; Schully, KL; Sharma, S1
Cottam, HB; Guiney, DG; Sabet, M1

Other Studies

2 other study(ies) available for resiquimod and Anthrax

ArticleYear
Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by bacillus anthracis.
    Pharmaceutical research, 2013, Volume: 30, Issue:5

    Topics: Acetylation; Animals; Anthrax; Anthrax Vaccines; Antibody Formation; Antigens, Bacterial; Bacillus anthracis; Bacterial Toxins; Dextrans; Drug Carriers; Imidazoles; Mice; Toll-Like Receptors; Vaccination; Vaccines, Subunit

2013
Modulation of cytokine production and enhancement of cell viability by TLR7 and TLR9 ligands during anthrax infection of macrophages.
    FEMS immunology and medical microbiology, 2006, Volume: 47, Issue:3

    Topics: Aminoquinolines; Animals; Anthrax; Bacillus anthracis; Cell Survival; Cells, Cultured; Cytokines; Imidazoles; Ligands; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred A; Spores, Bacterial; Toll-Like Receptor 7; Toll-Like Receptor 9

2006